About CLINUVEL

Contact

Head Office

CLINUVEL PHARMACEUTICALS LIMITED,
Level 6,
15 Queen Street,
Melbourne
Victoria 3000
Australia

Tel: +61 3 9660 4900
Fax: +61 3 9660 4909
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

UK office

Wesley House,
Bull Hill
Leatherhead, KT22 7AH
United Kingdom

Tel: +44 1372 860 765

Singapore office

9 Temasek Blvd #29-01
Singapore 038989

US Office

PO BOX 7388,
Menlo Park, CA 94026

Tel: +1 372 860 765

Swiss Office

Zugerstrasse 76a,
6340 Baar,
Switzerland

Tel: +41 41 763 1782
Fax: +41 41 763 1784
 

 

 

CLINUVEL receives a large number of inquiries every day. For a list of frequently asked questions, please click here.

For more information on CLINUVEL’s program for SCENESSE® in EPP, please go to the following page.

For more information on CLINUVEL’s program for SCENESSE® in Vitiligo, please go to the following page.

If you have any additional questions, you can send us a message by filling out this online form.
If you have any investor related questions, you can send us a message by filling out this online form.
If you experience any side effects while using a CLINUVEL product, please feel free to contact us at This email address is being protected from spambots. You need JavaScript enabled to view it.

Latest Company Announcements

31 January 2017

Appendix 4C - Quarterly report

Quarterly report

Read More
23 December 2016

Appendix 3Y

Change of Director’s Interest Notice

Read More
20 December 2016

CLINUVEL Newsletter - December 2016

At the end of a calendar year we look back on plenty of activities and a solid financial performance by the CLINUVEL Group.

Read More
12 December 2016

Appendix 3Y

Change of Director’s Interest Notice

Read More
28 November 2016

Results of Meeting

AGM results

Read More
27 November 2016

Chair's Address to the Annual General Meeting

I would like to commence my address by saying it is always a pleasure to welcome familiar and a few new faces to the CLINUVEL Annual General meeting.

Read More

Quick Links